Table 3.
Patient outcome
| No | Response | Relapse | PFS | OS | Comments |
|---|---|---|---|---|---|
| 1 | CR | No | +38 m | +38 m | Alive in CR and GVHD free |
| 2 | CR | No | +34 m | +34 m | Alive in CR and GVHD free |
| 3 | No response | No response | N/A | 3 m | Never responded – died due to infection |
| 4 | CR | No | 20 m | 20 m | Died in CR from intestinal vasculitis (GVHD?) |
| 5 | CR* | No | +52 m | +52 m | Alive in CR with active sclerodermoid GVHD under treatment |
| 6 | CR* | No | 51 m | 51 m | Died in CR due to dilated cardiomyopathy present before transplantation |
| 7 | CR | No | +24 | +24 | Alive in CR and GVHD free |
| 8 | CR | No | +20 | +20 | Alive in CR with inactive GVHD under treatment with ruxolitinib |
| 9 | CR* | Yes | +4 | +16 | Alive in CR and GVHD free |
| 10 | CR** | Yes | +2 | +5 | Alive in CR and GVHD free |
*
CR achieved after DLI administration.
**
CR achieved after CyA withdrawal.